Where does Takara BIO Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Takara BIO Inc. ranks #6,388 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Takara BIO Inc. hold?

Takara BIO Inc. holds 53 US utility patents granted between 2015 and 2025, spanning 14 technology areas.

What is Takara BIO Inc.'s Innovation Score?

Takara BIO Inc. has an Innovation Score of 36.0 out of 100 (top 48% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Takara BIO Inc.'s patent grant rate increasing or decreasing?

Takara BIO Inc.'s recent grant velocity is -66% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Takara BIO Inc.'s patents?

Takara BIO Inc.'s patents average 7.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Takara BIO Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Takara BIO Inc.

Q: What technology areas does Takara BIO Inc. focus on?

Takara BIO Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 50 patents. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 53 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Takara ranks #6,388 of 50,000 tracked US assignees by granted-patent volume, with 53 patents across 14 technology areas.

#6,388
of 50,000 US assignees by volume: Top 48%
by Innovation Score (36.0/100): 7.9
avg claims per patent: -66%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6388 · Foreign Corporation #6,388 · 53 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 53 grants
UPPER-Q #6,388/50,000
PHOTO-FINISH Schwäbische Hüttenwe…
CPC-FOCUS C12N · 14 areas
INNOV-THIN 36.0/100
CLAIMS-SPARSE 7.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -66% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Schwäbische Hüttenwerke Automotive Gmbh (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Korea Internet & Sec… · near

36
Viavi Solutions UK · near

36
Takara BIO · this assignee

36
Thermo Fisher Scient… · near

36
Activevideo Networks · near

36
3D Lighting Innovati… · lowest

7

What this shows Takara BIO Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-SPARSE, TYPE-FRNCORP, VEL-DROP, BOOK-FULL. Volume places it #6,388 of 50,000; Innovation Score 36.0/100 sits in the top 48% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Schwäbische Hüttenwerke Automotive Gmbh (±0 grants).

Portfolio overview

Takara BIO Inc. has been granted 53 US utility patents between 2015 and 2025, placing Takara BIO Inc. at #6,388 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.9 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Takara BIO Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Takara sits between Schwäbische Hüttenwerke Automotive Gmbh (53 patents, rank #6,382) and TPI Composites, Inc. (53 patents, rank #6,390) - the closest US assignees by grant volume. The composite Innovation Score of 36.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 13 grants, compared with 38 in the 2015–2019 window, a -66% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Takara BIO Inc.'s 7.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 14 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Schwäbische Hütte…

53
Shoretel

53
Solaria

53
Suprema

53
Taris Biomedical

53
Tenga

53
Thine

53
TPI Composites

53
Takara BIO ◀

53

What this shows Takara holds 53 patents at rank #6,386, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Takara

By rank, the assignees closest to #6,386 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Takara's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Takara, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Thermo Fisher Scientific Messtechnik Gmbh 36 Viavi Solutions UK Limited 36 Korea Internet & Security Agency 36 Activevideo Networks, Llc 36

Similar claim depth

Nearest assignees by average claims per patent (7.9 here).

Southeast University 7.9 avg Midmark Corporation 7.9 avg Kabushiki Kaisha Pilot Corporation 7.9 avg NHK Spring Co., Ltd. 7.9 avg

Takara's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Takara BIO Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	12	22.6%
2016	9	17.0%
2017	6	11.3%
2018	6	11.3%
2019	5	9.4%
2020	3	5.7%
2021	3	5.7%
2022	3	5.7%
2023	1	1.9%
2024	3	5.7%
2025partial year	2	3.8%

Which technologies does Takara BIO Inc. patent most?

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 50

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 17

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 16

C07K - PEPTIDES 15

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 14

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 12

C12Y - ENZYMES 10

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 1

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 1

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 1

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 1

Top 14 of 14 technology areas

Where it ranks

Overall rank by patents

#6,388

of 50,000 tracked assignees

Innovation Score

36.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.